In conclusion, we show that the rs10191329 variant is associated with more extensive pathological changes in MS, such as an increased susceptibility to tissue damage and increased myeloid cell activation and disclose both DYSF and ZNF638, as well as mitochondrial pathways as potential candidates underlying these effects. Here, ZNF638 is linked to myeloid sarcoma.